Legis Daily

FAST Generics Act of 2019

USA116th CongressHR-985| House 
| Updated: 2/5/2019
Peter Welch

Peter Welch

Democratic Representative

Vermont

Cosponsors (4)
David N. Cicilline (Democratic)David B. McKinley (Republican)Matt Cartwright (Democratic)Elissa Slotkin (Democratic)

Energy and Commerce Committee

  • Introduced
  • In Committee
  • On Floor
  • Passed Chamber
  • Enacted
Fair Access for Safe and Timely Generics Act of 2019 or the FAST Generics Act of 2019 This bill generally prohibits the license holder of a drug or biological product approved by the Food and Drug Administration from restricting availability of the drug or product for testing by a product developer seeking to develop a drug, generic drug, or biosimilar.
View Full Text

Suggested Questions

Get AI-generated questions to help you understand this bill better

Timeline
Feb 5, 2019
Introduced in House
Feb 5, 2019
Referred to the House Committee on Energy and Commerce.
  • February 5, 2019
    Introduced in House
  • February 5, 2019
    Referred to the House Committee on Energy and Commerce.

Health

Competition and antitrustDrug safety, medical device, and laboratory regulationLicensing and registrationsPrescription drugs

FAST Generics Act of 2019

USA116th CongressHR-985| House 
| Updated: 2/5/2019
Fair Access for Safe and Timely Generics Act of 2019 or the FAST Generics Act of 2019 This bill generally prohibits the license holder of a drug or biological product approved by the Food and Drug Administration from restricting availability of the drug or product for testing by a product developer seeking to develop a drug, generic drug, or biosimilar.
View Full Text

Suggested Questions

Get AI-generated questions to help you understand this bill better

Timeline
Feb 5, 2019
Introduced in House
Feb 5, 2019
Referred to the House Committee on Energy and Commerce.
  • February 5, 2019
    Introduced in House
  • February 5, 2019
    Referred to the House Committee on Energy and Commerce.
Peter Welch

Peter Welch

Democratic Representative

Vermont

Cosponsors (4)
David N. Cicilline (Democratic)David B. McKinley (Republican)Matt Cartwright (Democratic)Elissa Slotkin (Democratic)

Energy and Commerce Committee

Health

  • Introduced
  • In Committee
  • On Floor
  • Passed Chamber
  • Enacted
Competition and antitrustDrug safety, medical device, and laboratory regulationLicensing and registrationsPrescription drugs